ASGCT Statement on Germline Gene Editing Practices
ASGCT Executive Committee | November 26, 2018
The American Society of Gene & Cell Therapy (ASGCT) considers it wholly unacceptable to use germline gene editing and the implantation of gene-edited embryos to achieve a pregnancy without extensive research into the safety, efficacy, and legality of such applications. Any announcements of, or claims to have begun, such studies in germline gene editing are compromised, both ethically and scientifically.
Position Statements
Read Full Story